Rubella
📧 Sign up to get email alerts when something new happens for Rubella.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 3]
A Phase 3 trial assessed the immunogenicity and safety of a combined measles, mumps, rubella and varicella vaccine (MMRV) developed by Glaxo…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases [Phase 4]
This Phase 4 trial update reports on the immunogenicity and safety of a combined measles, mumps, rubella, and varicella vaccine developed by…
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. [Phase 4]
Phase 4 trial update evaluating GSK's MMR vaccine Priorix in healthy children aged 12 to 18 months in Singapore.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine [Phase 3]
This document reports long-term immunogenicity and safety results from a Phase 3 trial of the MMRV vaccine, evaluating durability of immune …
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines [Phase 4]
Phase 4 trial assessing immunogenicity when measles vaccine is co-administered with a Japanese encephalitis vaccine; the study has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. [Phase 3]
Phase 3 trial evaluating immunogenicity, reactogenicity and safety of a combined Measles, Mumps and Rubella vaccine produced by Bio-Manguinh…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations [Phase 4]
Phase 4 clinical trial comparing immunogenicity of single-dose versus multidose measles-mumps-rubella vaccine presentations completed.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella [Phase 1]
Phase 1 trial evaluating safety and immunogenicity of a measles-rubella double-antigen vaccine; the study sponsored by Bio-Manguinhos/Fiocru…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED) [Phase 3]
This update reports the completion of a Phase 3 study evaluating Merck's Measles, Mumps, Rubella, and Varicella vaccine (ProQuad) in healthy…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: MMR and Varicella Vaccine in Premature Infants
A completed clinical trial evaluating the MMR vaccine and the varicella vaccine in premature infants.
-
CLINICAL_TRIALS research · 2015-05-04Clinical Trial Update: Comparison of Immunization Quality Improvement Dissemination Study [NA]
This is a completed clinical trial examining a immunization quality improvement dissemination study sponsored by Children's National Researc…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Making Decisions About the Measles-Mumps-Rubella Vaccine [NA]
This clinical trial update discusses decisions about the Measles-Mumps-Rubella vaccine (MMR). The University of Michigan–sponsored study is …
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers [Phase 3]
A Phase 3 trial in Taiwanese toddlers evaluated co-administration of a Japanese Encephalitis chimeric virus vaccine with a Measles-Mumps-Rub…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of an alternative manufacturing process for MMRV vaccine (AMP) with comple…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine [Phase 4]
Phase 4 trial evaluating immunogenicity and safety when a Hepatitis A vaccine is given at the same time as the Measles, Mumps, and Rubella v…
-
CLINICAL_TRIALS withdrawal · 2013-07-22Clinical Trial Update: Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the Philippines
Clinical trial update indicating the safety study of Priorix-Tetra (MMRV vaccine) in children in the Philippines has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)
Completed serology study in children aged 12 to 23 months who received the Measles, Mumps, and Rubella (MMR) vaccine. Sponsored by Bio-Mangu…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants [Phase 2, Phase 3]
This clinical trial update reports on the immunogenicity and reactogenicity of the trivalent measles-mumps-rubella vaccine Trivivac in healt…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: A Study of ProQuad™ in Healthy Children in Korea (V221-023) [Phase 3]
Phase 3 trial of ProQuad in healthy children in Korea was terminated; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age [Phase 2]
Phase 2 trial evaluating the immunogenicity of GSK's MMR vaccine (209762) compared with M-M-R II when co-administered with routine vaccines …
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers [Phase 3]
A Phase 3 safety study evaluating the co-administration of Menactra meningococcal vaccine with other pediatric vaccines in healthy toddlers;…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers [Phase 3]
This Phase 3 trial evaluated the immunogenicity and safety of pediatric vaccines administered with Menactra in healthy toddlers, with result…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers [Phase 3]
A Phase 3 study evaluated two doses of Menactra meningococcal conjugate vaccine in healthy toddlers. The trial is completed and results were…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Immune Responses to Two Dose Varivax +/- MMR-II [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing immune responses to two doses of Varivax with or without MMR-II in measles, mumps, rubella, and varicel…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
The trial update describes immune responses of premature infants to the Measles-Mumps-Rubella (MMR) and Varicella vaccines, with the study s…